Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
18 | 3 | HEMATOLOGY//THROMBOSIS AND HAEMOSTASIS//THROMBOSIS RESEARCH | 124610 |
922 | 2 | WARFARIN//DABIGATRAN//RIVAROXABAN | 11329 |
875 | 1 | DABIGATRAN//RIVAROXABAN//APIXABAN | 3036 |
1141 | 1 | MASSIVE TRANSFUSION//COAGULOPATHY//THROMBOELASTOGRAPHY | 2855 |
2249 | 1 | CYP2C9//VKORC1//WARFARIN | 2344 |
6758 | 1 | PROTHROMBIN TIME//INTERNATIONAL NORMALIZED RATIO//INR | 1473 |
11748 | 1 | RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA//RFVIIA | 985 |
17259 | 1 | PROTHROMBIN COMPLEX CONCENTRATE//ANTICOAGULATION REVERSAL//WARFARIN REVERSAL | 636 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | WARFARIN | authKW | 1586012 | 13% | 38% | 1503 |
2 | DABIGATRAN | authKW | 1338249 | 6% | 75% | 642 |
3 | RIVAROXABAN | authKW | 1310259 | 6% | 71% | 665 |
4 | APIXABAN | authKW | 902308 | 4% | 76% | 426 |
5 | CYP2C9 | authKW | 805672 | 4% | 63% | 461 |
6 | VKORC1 | authKW | 606197 | 2% | 82% | 265 |
7 | COAGULOPATHY | authKW | 474183 | 4% | 37% | 467 |
8 | EDOXABAN | authKW | 437401 | 2% | 83% | 189 |
9 | PROTHROMBIN COMPLEX CONCENTRATE | authKW | 432404 | 2% | 79% | 198 |
10 | INTERNATIONAL NORMALIZED RATIO | authKW | 407840 | 2% | 57% | 259 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Hematology | 80203 | 26% | 1% | 2930 |
2 | Peripheral Vascular Diseases | 41140 | 18% | 1% | 2046 |
3 | Critical Care Medicine | 20602 | 9% | 1% | 972 |
4 | Anesthesiology | 12653 | 7% | 1% | 756 |
5 | Pharmacology & Pharmacy | 8659 | 18% | 0% | 2050 |
6 | Emergency Medicine | 5165 | 3% | 1% | 345 |
7 | Cardiac & Cardiovascular System | 4800 | 9% | 0% | 1048 |
8 | Medicine, General & Internal | 4633 | 11% | 0% | 1223 |
9 | Surgery | 2996 | 11% | 0% | 1222 |
10 | Medical Laboratory Technology | 1796 | 2% | 0% | 264 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | TRANSLAT INJURY | 119806 | 1% | 47% | 91 |
2 | C ITAL REG BLOOD BANK | 104816 | 1% | 58% | 65 |
3 | HAEMOSTASIS THROMBOSIS | 66936 | 1% | 25% | 98 |
4 | TRANSFUS MED SECT | 65384 | 1% | 41% | 57 |
5 | HAEMOPHILIA THROMBOSIS | 42393 | 0% | 28% | 55 |
6 | TRAUMA CRIT CARE ACUTE CARE SURG | 38255 | 0% | 33% | 42 |
7 | ECAA CENT IL | 36140 | 0% | 100% | 13 |
8 | HEAD ORTHOPED | 32410 | 0% | 32% | 36 |
9 | ECAA | 30580 | 0% | 100% | 11 |
10 | EAA CENT IL | 27800 | 0% | 100% | 10 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 69147 | 2% | 11% | 220 |
2 | BLOOD COAGULATION & FIBRINOLYSIS | 48283 | 2% | 7% | 242 |
3 | THROMBOSIS AND HAEMOSTASIS | 47659 | 4% | 4% | 418 |
4 | JOURNAL OF TRAUMA AND ACUTE CARE SURGERY | 43478 | 2% | 8% | 189 |
5 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 39786 | 2% | 6% | 242 |
6 | THROMBOSIS RESEARCH | 33579 | 3% | 3% | 356 |
7 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 19849 | 1% | 5% | 140 |
8 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 14873 | 1% | 6% | 96 |
9 | PHARMACOGENOMICS | 12677 | 1% | 5% | 92 |
10 | PHARMACOTHERAPY | 9659 | 1% | 3% | 128 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | WARFARIN | 1586012 | 13% | 38% | 1503 | Search WARFARIN | Search WARFARIN |
2 | DABIGATRAN | 1338249 | 6% | 75% | 642 | Search DABIGATRAN | Search DABIGATRAN |
3 | RIVAROXABAN | 1310259 | 6% | 71% | 665 | Search RIVAROXABAN | Search RIVAROXABAN |
4 | APIXABAN | 902308 | 4% | 76% | 426 | Search APIXABAN | Search APIXABAN |
5 | CYP2C9 | 805672 | 4% | 63% | 461 | Search CYP2C9 | Search CYP2C9 |
6 | VKORC1 | 606197 | 2% | 82% | 265 | Search VKORC1 | Search VKORC1 |
7 | COAGULOPATHY | 474183 | 4% | 37% | 467 | Search COAGULOPATHY | Search COAGULOPATHY |
8 | EDOXABAN | 437401 | 2% | 83% | 189 | Search EDOXABAN | Search EDOXABAN |
9 | PROTHROMBIN COMPLEX CONCENTRATE | 432404 | 2% | 79% | 198 | Search PROTHROMBIN+COMPLEX+CONCENTRATE | Search PROTHROMBIN+COMPLEX+CONCENTRATE |
10 | INTERNATIONAL NORMALIZED RATIO | 407840 | 2% | 57% | 259 | Search INTERNATIONAL+NORMALIZED+RATIO | Search INTERNATIONAL+NORMALIZED+RATIO |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |